 |
|
COMMENTS & OPINIONS
Whether to Repeat Thyroid Disease Screening—Reply
Joseph Meyerovitch, MD;
Pnina Rotman-Pikielny, MD;
Michael Sherf, MD, MPH;
Erez Battat, MBA;
Yair Levy, MD;
Martin I. Surks, MD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We are in general agreement with the comments of Goichot and Vinzio that there is a selection bias in the population. Our 5-year study of the natural history of patients who had initial TSH determinations in 2002 excluded pregnant women and patients who received treatment with levothyroxine or antithyroid drugs (n = 15 081; 3.56% and not 37% as Goichot and Vinzio wrote).1 We already mentioned in the "Comment" section that lack of clinical information about why patients were treated or not treated with thyroid-specific medication raises the possibility that the group we studied may not be entirely representative of patients with abnormal TSH levels. With regard to screening, we also mentioned in the "Comment" section that our data support the recent evidence-based recommendations against population-based screening.
AUTHOR INFORMATION
Correspondence: Dr Meyerovitch, Department . . . [Full Text of this Article]
RELATED LETTER
Whether to Repeat Thyroid Disease Screening
Bernard Goichot and Stéphane Vinzio
Arch Intern Med. 2008;168(3):330.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Serum Thyrotropin Measurements in the Community: Five-Year Follow-up in a Large Network of Primary Care Physicians
Joseph Meyerovitch, Pnina Rotman-Pikielny, Michael Sherf, Erez Battat, Yair Levy, and Martin I. Surks
Arch Intern Med. 2007;167(14):1533-1538.
ABSTRACT
| FULL TEXT
|
